124 related articles for article (PubMed ID: 15194246)
1. Is GSK guilty of fraud?
Lancet
Lancet; 2004 Jun; 363(9425):1919. PubMed ID: 15194246
[No Abstract] [Full Text] [Related]
2. Professor files complaint of scientific misconduct over allegation of ghostwriting.
Roehr B
BMJ; 2011 Jul; 343():d4458. PubMed ID: 21752841
[No Abstract] [Full Text] [Related]
3. Antidepressants and children. Buried data can be hazardous to a company's health.
Marshall E
Science; 2004 Jun; 304(5677):1576-7. PubMed ID: 15192185
[No Abstract] [Full Text] [Related]
4. Spitzer sues drug giant for deceiving doctors.
Wadman M
Nature; 2004 Jun; 429(6992):589. PubMed ID: 15190317
[No Abstract] [Full Text] [Related]
5. Depressing misrepresentation?
Newton J; Langlands A
Lancet; 2004 May; 363(9422):1732. PubMed ID: 15158640
[No Abstract] [Full Text] [Related]
6. Judge might reopen GSK paroxetine case.
Dyer C
BMJ; 2016 Feb; 352():i800. PubMed ID: 26858261
[No Abstract] [Full Text] [Related]
7. Putting GlaxoSmithKline to the test over paroxetine.
Doshi P
BMJ; 2013 Nov; 347():f6754. PubMed ID: 24222673
[No Abstract] [Full Text] [Related]
8. Exacerbation of extrapyramidal symptoms with paroxetine.
Arya DK; McKenzie J; Worrall N
Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
[No Abstract] [Full Text] [Related]
9. GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects.
Tanne JH
BMJ; 2009 Oct; 339():b4266. PubMed ID: 19833704
[No Abstract] [Full Text] [Related]
10. Withdrawal after discontinuation of paroxetine.
Arya DK
Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
[No Abstract] [Full Text] [Related]
11. Paxil and self-scratching.
Weintrob A
J Am Acad Child Adolesc Psychiatry; 2001 Jan; 40(1):5. PubMed ID: 11195562
[No Abstract] [Full Text] [Related]
12. The paroxetine 352 bipolar trial: A study in medical ghostwriting.
Amsterdam JD; McHenry LB
Int J Risk Saf Med; 2012; 24(4):221-31. PubMed ID: 23135337
[TBL] [Abstract][Full Text] [Related]
13. Paroxetine: a review of clinical experience.
Dunner D; Kumar R
Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
[TBL] [Abstract][Full Text] [Related]
14. Lower gastrointestinal bleeding and paroxetine use: two case reports.
Blasco-Fontecilla H; de Leon J
Psychosomatics; 2012; 53(2):184-7. PubMed ID: 22424167
[No Abstract] [Full Text] [Related]
15. GlaxoSmithKline to publish clinical trials after US lawsuit.
Gibson L
BMJ; 2004 Jun; 328(7455):1513. PubMed ID: 15217848
[No Abstract] [Full Text] [Related]
16. Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy.
Diler RS; Tamam L; Avci A
J Clin Psychopharmacol; 2000 Oct; 20(5):586-7. PubMed ID: 11001250
[No Abstract] [Full Text] [Related]
17. Olanzapine in the treatment of resistant depression.
Caetano D; Caetano SC
Aust N Z J Psychiatry; 2005; 39(1-2):108-9. PubMed ID: 15660713
[No Abstract] [Full Text] [Related]
18. Paroxetine-induced bruxism effectively treated with tandospirone.
Kishi Y
J Neuropsychiatry Clin Neurosci; 2007; 19(1):90-1. PubMed ID: 17308240
[No Abstract] [Full Text] [Related]
19. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].
Vergouwen AC; Bakker A
Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241
[TBL] [Abstract][Full Text] [Related]
20. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Krol DG; Nolen WA
Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
